United States Biotechnology & Medical Research

Compass Therapeutics Inc. (CMPX)

Compass Therapeutics recently saw Chief Accounting Officer Neil Lerner acquire shares totaling 21,250 dollars over two separate transactions. This activity follows a period of significant stock price decline. Despite a recent earnings report missing expectations, these insider purchases represent the only notable market movements within the last ninety days for the healthcare firm.
Ticker: CMPX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Compass Therapeutics Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.8
Lerner Neil Chief Accounting Officer Officer
Transaction date
Purchase
Price
27.10
Quantity 55,790 -23.4%
Value US$2,496,601
3.8
Lerner Neil Chief Accounting Officer Officer
Transaction date
Purchase
Price
48.03
Quantity 38,988 -23.6%
Value US$4,505,748
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
492.10
Quantity 81,301 -4.6%
Value US$4,754,631
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Sale
Price
1.59
Quantity 3,571,428 -100.0%
Value US$5,678,571
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Sale
Price
1.59
Quantity 3,571,428 -100.0%
Value US$5,678,571
The Biotech Growth Trust PLC Director; Shareholder Non-Executive Director
Transaction date
Proposed sale
Price
1.59
Quantity 3,571,428
Value US$5,678,571
3.3
Anderman Jonathan Gen Counsel & Corporate Sec Officer
Transaction date
Purchase
Price
1.54
Quantity 20,000 +2000.0%
Value US$30,800
3.8
Lerner Neil CHIEF ACCOUNTING OFFICER Officer
Transaction date
Purchase
Price
1.42
Quantity 20,000 +6.7%
Value US$28,400
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
3.37
Quantity 10,000 +0.2%
Value US$33,700
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
3.98
Quantity 20,000 +0.3%
Value US$79,600
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
3.86
Quantity 20,000 +0.3%
Value US$77,200
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
4.05
Quantity 20,000 +0.4%
Value US$81,000
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
4.19
Quantity 20,000 +0.4%
Value US$83,800
2.6
Bisker-Leib Vered Chief Operating Officer Officer
Transaction date
Sale
Price
4.36
Quantity 2 -0.0%
Value US$9
2.6
Bisker-Leib Vered Chief Operating Officer Officer
Transaction date
Sale
Price
4.30
Quantity 9,569 -0.9%
Value US$41,147
2.6
Bisker-Leib Vered Chief Operating Officer Officer
Transaction date
Sale
Price
4.19
Quantity 14,929 -1.4%
Value US$62,553
2.6
Bisker-Leib Vered Chief Operating Officer Officer
Transaction date
Sale
Price
4.34
Quantity 16,035 -1.5%
Value US$69,592
2.6
Bisker-Leib Vered Chief Operating Officer Officer
Transaction date
Sale
Price
4.40
Quantity 6,226 -0.6%
Value US$27,394
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
3.21
Quantity 402,000 +2.7%
Value US$1,290,420
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
3.21
Quantity 402,000 +2.7%
Value US$1,290,420
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
2.32
Quantity 10,000 +0.2%
Value US$23,200
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
2.27
Quantity 15,000 +0.3%
Value US$34,050
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
3.03
Quantity 15,000 +0.3%
Value US$45,450
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
2.83
Quantity 15,000 +0.3%
Value US$42,450
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
3.05
Quantity 15,000 +0.3%
Value US$45,750
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
2.64
Quantity 15,000 +0.3%
Value US$39,600
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
2.58
Quantity 15,000 +0.3%
Value US$38,700
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
2.80
Quantity 20,000 +0.4%
Value US$56,000
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
2.34
Quantity 20,000 +0.4%
Value US$46,800
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
2.29
Quantity 30,000 +0.6%
Value US$68,700
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
2.83
Quantity 30,000 +0.6%
Value US$84,900
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
3.03
Quantity 20,000 +0.4%
Value US$60,600
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
3.04
Quantity 20,000 +0.4%
Value US$60,800
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
2.72
Quantity 18,355 +0.4%
Value US$49,926
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
2.47
Quantity 20,215 +0.4%
Value US$49,931
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
2.49
Quantity 30,722 +0.2%
Value US$76,498
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
2.49
Quantity 30,722 +0.2%
Value US$76,498
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
2.35
Quantity 97,094 +0.7%
Value US$228,171
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
2.35
Quantity 97,094 +0.7%
Value US$228,171
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.79
Quantity 64,700 +0.4%
Value US$115,813
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.79
Quantity 64,700 +0.4%
Value US$115,813
3.6
Schuetz Thomas J. CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
1.80
Quantity 27,836 +0.5%
Value US$50,105
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.60
Quantity 24,447 +0.2%
Value US$39,115
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.60
Quantity 24,447 +0.2%
Value US$39,115
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.56
Quantity 90,712 +0.6%
Value US$141,511
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.56
Quantity 90,712 +0.6%
Value US$141,511
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.63
Quantity 10,200 +0.1%
Value US$16,626
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
1.63
Quantity 10,200 +0.1%
Value US$16,626
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
3.50
Quantity 3,571,428 New position
Value US$12,499,998
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
3.50
Quantity 1,785,715 +14.0%
Value US$6,250,002
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
3.50
Quantity 3,571,428 New position
Value US$12,499,998
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
3.50
Quantity 1,785,715 +14.0%
Value US$6,250,002
Ferneau Philip Non-Executive Director
Transaction date
Purchase
Price
5.00
Quantity 250,000 +166.4%
Value US$1,250,000
Sunderland Julie Non-Executive Director
Transaction date
Purchase
Price
5.00
Quantity 289,118 +13.1%
Value US$1,445,590
Ferneau Philip Non-Executive Director
Transaction date
Purchase
Price
5.00
Quantity 64,066 +2.8%
Value US$320,330
1.5
GORDON CARL L Non-Executive Director Large shareholder
Transaction date
Purchase
Price
5.00
Quantity 1,455,132 +12.9%
Value US$7,275,660
3.6
Schuetz Thomas J. Chief Executive Officer Executive Director
Transaction date
Purchase
Price
5.00
Quantity 97,431 +2.2%
Value US$487,155
2.6
ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
5.00
Quantity 1,455,132 +12.9%
Value US$7,275,660
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-02 2026-10-01 B Purchase
3.8
Lerner Neil

Chief Accounting Officer

Officer
55,790 -23.4%
27.10
US$2,496,601 		55,790 -23.4% 27.10 US$2,496,601
2026-09-25 2026-09-24 B Purchase
3.8
Lerner Neil

Chief Accounting Officer

Officer
38,988 -23.6%
48.03
US$4,505,748 		38,988 -23.6% 48.03 US$4,505,748
2025-05-27 2025-05-27 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
81,301 -4.6%
492.10
US$4,754,631 		81,301 -4.6% 492.10 US$4,754,631
2025-04-11 2025-04-09 S Sale
1.5
GORDON CARL L
Non-Executive Director Large shareholder
3,571,428 -100.0%
1.59
US$5,678,571 		3,571,428 -100.0% 1.59 US$5,678,571
2025-04-11 2025-04-09 S Sale
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
3,571,428 -100.0%
1.59
US$5,678,571 		3,571,428 -100.0% 1.59 US$5,678,571
2025-04-09 2025-04-09 PrS Proposed sale
2.6
OrbiMed Genesis Master Fund, L.P.

Director; Shareholder

Non-Executive Director
3,571,428
1.59
US$5,678,571 		3,571,428 1.59 US$5,678,571
2025-04-09 2025-04-09 PrS Proposed sale
The Biotech Growth Trust PLC

Director; Shareholder

Non-Executive Director
3,571,428
1.59
US$5,678,571 		3,571,428 1.59 US$5,678,571
2025-04-08 2025-04-07 B Purchase
3.3
Anderman Jonathan

Gen Counsel & Corporate Sec

Officer
20,000 +2000.0%
1.54
US$30,800 		20,000 +2000.0% 1.54 US$30,800
2025-04-08 2025-04-07 B Purchase
3.8
Lerner Neil

CHIEF ACCOUNTING OFFICER

Officer
20,000 +6.7%
1.42
US$28,400 		20,000 +6.7% 1.42 US$28,400
2023-03-10 2023-03-10 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
10,000 +0.2%
3.37
US$33,700 		10,000 +0.2% 3.37 US$33,700
2023-02-27 2023-02-27 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
20,000 +0.3%
3.98
US$79,600 		20,000 +0.3% 3.98 US$79,600
2023-02-15 2023-02-15 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
20,000 +0.3%
3.86
US$77,200 		20,000 +0.3% 3.86 US$77,200
2023-01-31 2023-01-31 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
20,000 +0.4%
4.05
US$81,000 		20,000 +0.4% 4.05 US$81,000
2023-01-24 2023-01-24 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
20,000 +0.4%
4.19
US$83,800 		20,000 +0.4% 4.19 US$83,800
2022-11-25 2022-11-25 S Sale
2.6
Bisker-Leib Vered

Chief Operating Officer

Officer
2 -0.0%
4.36
US$9 		2 -0.0% 4.36 US$9
2022-11-25 2022-11-23 S Sale
2.6
Bisker-Leib Vered

Chief Operating Officer

Officer
9,569 -0.9%
4.30
US$41,147 		9,569 -0.9% 4.30 US$41,147
2022-11-25 2022-11-22 S Sale
2.6
Bisker-Leib Vered

Chief Operating Officer

Officer
14,929 -1.4%
4.19
US$62,553 		14,929 -1.4% 4.19 US$62,553
2022-11-22 2022-11-21 S Sale
2.6
Bisker-Leib Vered

Chief Operating Officer

Officer
16,035 -1.5%
4.34
US$69,592 		16,035 -1.5% 4.34 US$69,592
2022-11-22 2022-11-18 S Sale
2.6
Bisker-Leib Vered

Chief Operating Officer

Officer
6,226 -0.6%
4.40
US$27,394 		6,226 -0.6% 4.40 US$27,394
2022-11-10 2022-11-08 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
402,000 +2.7%
3.21
US$1,290,420 		402,000 +2.7% 3.21 US$1,290,420
2022-11-10 2022-11-08 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
402,000 +2.7%
3.21
US$1,290,420 		402,000 +2.7% 3.21 US$1,290,420
2022-09-28 2022-09-28 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
10,000 +0.2%
2.32
US$23,200 		10,000 +0.2% 2.32 US$23,200
2022-09-27 2022-09-26 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
15,000 +0.3%
2.27
US$34,050 		15,000 +0.3% 2.27 US$34,050
2022-09-08 2022-09-07 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
15,000 +0.3%
3.03
US$45,450 		15,000 +0.3% 3.03 US$45,450
2022-09-01 2022-09-01 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
15,000 +0.3%
2.83
US$42,450 		15,000 +0.3% 2.83 US$42,450
2022-08-17 2022-08-17 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
15,000 +0.3%
3.05
US$45,750 		15,000 +0.3% 3.05 US$45,750
2022-08-10 2022-08-10 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
15,000 +0.3%
2.64
US$39,600 		15,000 +0.3% 2.64 US$39,600
2022-08-02 2022-08-01 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
15,000 +0.3%
2.58
US$38,700 		15,000 +0.3% 2.58 US$38,700
2022-06-21 2022-06-21 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
20,000 +0.4%
2.80
US$56,000 		20,000 +0.4% 2.80 US$56,000
2022-06-17 2022-06-16 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
20,000 +0.4%
2.34
US$46,800 		20,000 +0.4% 2.34 US$46,800
2022-06-13 2022-06-13 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
30,000 +0.6%
2.29
US$68,700 		30,000 +0.6% 2.29 US$68,700
2022-06-07 2022-06-06 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
30,000 +0.6%
2.83
US$84,900 		30,000 +0.6% 2.83 US$84,900
2022-06-01 2022-06-01 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
20,000 +0.4%
3.03
US$60,600 		20,000 +0.4% 3.03 US$60,600
2022-05-26 2022-05-26 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
20,000 +0.4%
3.04
US$60,800 		20,000 +0.4% 3.04 US$60,800
2022-05-24 2022-05-23 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
18,355 +0.4%
2.72
US$49,926 		18,355 +0.4% 2.72 US$49,926
2022-05-17 2022-05-17 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
20,215 +0.4%
2.47
US$49,931 		20,215 +0.4% 2.47 US$49,931
2022-05-13 2022-05-13 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
30,722 +0.2%
2.49
US$76,498 		30,722 +0.2% 2.49 US$76,498
2022-05-13 2022-05-13 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
30,722 +0.2%
2.49
US$76,498 		30,722 +0.2% 2.49 US$76,498
2022-05-13 2022-05-12 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
97,094 +0.7%
2.35
US$228,171 		97,094 +0.7% 2.35 US$228,171
2022-05-13 2022-05-12 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
97,094 +0.7%
2.35
US$228,171 		97,094 +0.7% 2.35 US$228,171
2022-05-13 2022-05-11 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
64,700 +0.4%
1.79
US$115,813 		64,700 +0.4% 1.79 US$115,813
2022-05-13 2022-05-11 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
64,700 +0.4%
1.79
US$115,813 		64,700 +0.4% 1.79 US$115,813
2022-05-10 2022-05-10 B Purchase
3.6
Schuetz Thomas J.

CHIEF EXECUTIVE OFFICER

Executive Director
27,836 +0.5%
1.80
US$50,105 		27,836 +0.5% 1.80 US$50,105
2022-05-10 2022-05-10 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
24,447 +0.2%
1.60
US$39,115 		24,447 +0.2% 1.60 US$39,115
2022-05-10 2022-05-10 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
24,447 +0.2%
1.60
US$39,115 		24,447 +0.2% 1.60 US$39,115
2022-05-10 2022-05-09 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
90,712 +0.6%
1.56
US$141,511 		90,712 +0.6% 1.56 US$141,511
2022-05-10 2022-05-09 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
90,712 +0.6%
1.56
US$141,511 		90,712 +0.6% 1.56 US$141,511
2022-05-10 2022-05-06 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
10,200 +0.1%
1.63
US$16,626 		10,200 +0.1% 1.63 US$16,626
2022-05-10 2022-05-06 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
10,200 +0.1%
1.63
US$16,626 		10,200 +0.1% 1.63 US$16,626
2021-11-08 2021-11-04 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
3,571,428 New position
3.50
US$12,499,998 		3,571,428 New position 3.50 US$12,499,998
2021-11-08 2021-11-04 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
1,785,715 +14.0%
3.50
US$6,250,002 		1,785,715 +14.0% 3.50 US$6,250,002
2021-11-08 2021-11-04 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
3,571,428 New position
3.50
US$12,499,998 		3,571,428 New position 3.50 US$12,499,998
2021-11-08 2021-11-04 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
1,785,715 +14.0%
3.50
US$6,250,002 		1,785,715 +14.0% 3.50 US$6,250,002
2020-06-23 2020-06-19 B Purchase
Ferneau Philip
Non-Executive Director
250,000 +166.4%
5.00
US$1,250,000 		250,000 +166.4% 5.00 US$1,250,000
2020-06-23 2020-06-19 B Purchase
Sunderland Julie
Non-Executive Director
289,118 +13.1%
5.00
US$1,445,590 		289,118 +13.1% 5.00 US$1,445,590
2020-06-23 2020-06-19 B Purchase
Ferneau Philip
Non-Executive Director
64,066 +2.8%
5.00
US$320,330 		64,066 +2.8% 5.00 US$320,330
2020-06-23 2020-06-19 B Purchase
1.5
GORDON CARL L
Non-Executive Director Large shareholder
1,455,132 +12.9%
5.00
US$7,275,660 		1,455,132 +12.9% 5.00 US$7,275,660
2020-06-23 2020-06-19 B Purchase
3.6
Schuetz Thomas J.

Chief Executive Officer

Executive Director
97,431 +2.2%
5.00
US$487,155 		97,431 +2.2% 5.00 US$487,155
2020-06-23 2020-06-19 B Purchase
2.6
ORBIMED ADVISORS LLC
Non-Executive Director Large shareholder
1,455,132 +12.9%
5.00
US$7,275,660 		1,455,132 +12.9% 5.00 US$7,275,660
Explore more

More insider trading research around Compass Therapeutics Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America